Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Third Culture Capital (3CC) is a venture capital firm based in the United States, dedicated to healthcare innovation. The firm focuses on early-stage investments, managing a portfolio of 15 companies with check sizes ranging from $250,000 to $1 million. 3CC was founded to support entrepreneurs who challenge the status quo in established markets.
3CC invests in early-stage companies at the intersection of software and substrate within the healthcare sector. Their investment range is approximately $250,000 to $1 million, targeting startups that aim to improve patient outcomes and enhance care experiences. The firm emphasizes the importance of unique life experiences in its investment approach.
Notable portfolio companies include AcousticaBio, a leader in advanced manufacturing for life; Aviwell, a microbiome discovery platform for food sustainability; Binkey, which offers healthcare payment processing solutions; and Boswell, providing services for underserved families. Other companies in their portfolio include Ciba Health, Docosan, Helm Health, Intus Care, KeyWise, Lime, Mahmee, Pragma Bio, Simplifed, Voiceitt, Vitaa, and Zuri Fertility.
Submit your pitch through their form at thirdculturecapital.com.
3CC typically participates in early-stage funding rounds, often leading investments in their target sectors.
The firm is open to follow-on investments, particularly in companies that demonstrate significant growth and alignment with their mission.
While specific fund size details are not disclosed, 3CC manages a portfolio of 15 companies with investments ranging from $250,000 to $1 million.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.